67
Pharmaceuticals
Nikon unit’s facility will be first in Asia to handle entire manufacturing process
Bristol Myers Squibb will partner with Nikon Cell Innovation to produce CAR-T treatments in Tokyo. (Bristol Myers Squibb)
HINAKO BANNO and MAYUKO SUZUKI
TOKYO — U.S. pharmaceutical giant Bristol Myers Squibb will produce advanced cancer immunotherapies in Japan, partnering with a Nikon pharmaceutical subsidiary to manufacture treatments that make use of the body’s immune cells.
